Study of Tolerance to Oral Peanut

Study of Tolerance to Oral Peanut: a randomised controlled trial of oral peanut immunotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN62416244

Enrollment

104

Registered

2010-04-29

Start date

2009-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Generic Health Relevance and Cross Cutting Themes

Interventions

There are two work packages: Package 1: The active group will undergo oral peanut immunotherapy (OIT - the intervention) and the control group will undergo a waiting list period of current standard m

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged greater than 7 years, either sex 2. Peanut allergy defined as a clear history of a typical immediate reaction following definite peanut ingestion

Exclusion criteria

Exclusion criteria: Major immunodeficiency (this will influence outcome)

Design outcomes

Primary

Measure	Time frame
Proportion of subjects in the active and control groups who pass a peanut challenge	—

Secondary

Measure	Time frame
1. Adverse effect of immunotherapy, laboratory assays	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026